학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 24건 | 목록 1~10
Academic Journal
Expert Review of Anticancer Therapy (EXPERT REV ANTICANCER THER), Sep2012; 12(9): 1129-1136. (8p)
Academic Journal
Journal of Clinical Oncology (J CLIN ONCOL), 12/1/2008; 26(34): 5647-5648. (2p)
Academic Journal
Gillessen S; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Università della Svizzera Italiana, Lugano, Switzerland. Electronic address: silke.gillessen@eoc.ch.; Bossi A; Genitourinary Oncology, Prostate Brachytherapy Unit, Gustave Roussy, Paris, France.; Davis ID; Monash University and Eastern Health, Victoria, Australia.; de Bono J; The Institute of Cancer Research, London, UK; Royal Marsden Hospital, London, UK.; Fizazi K; Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.; James ND; The Institute of Cancer Research, London, UK.; Mottet N; University Jean Monnet, St Etienne, France.; Shore N; Medical Director, Carolina Urologic Research Center, Myrtle Beach, SC, USA; CMO, Urology/Surgical Oncology, GenesisCare, Myrtle Beach, SC, USA.; Small E; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Smith M; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, Australia.; Tombal B; Cliniques universitaires Saint Luc, Brussels, Belgium.; Antonarakis ES; University of Minnesota Masonic Cancer Center, Minneapolis, MN, USA.; Aparicio AM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, NC, USA.; Attard G; University College London Cancer Institute, London, UK.; Beer TM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Beltran H; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Bjartell A; Department of Urology, Skåne University Hospital, Malmö, Sweden.; Blanchard P; Gustave Roussy, Département de Radiothérapie, Université Paris-Saclay, Oncostat, Inserm U-1018, F-94805, Villejuif, France.; Briganti A; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.; Bristow RG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Christie NHS Trust and CRUK Manchester Institute and Cancer Centre, Manchester, UK.; Bulbul M; Division of Urology, Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon.; Caffo O; Department of Medical Oncology, Santa Chiara Hospital, 38122 Trento, Italy.; Castellano D; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Castro E; Institute of Biomedical Research in Málaga (IBIMA), Málaga, Spain.; Cheng HH; University of Washington, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Chi KN; BC Cancer, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.; Chowdhury S; Guys and St Thomas's NHS Foundation Trust, London, United Kingdom.; Clarke CS; Research Department of Primary Care & Population Health, Royal Free Campus, University College London, London, UK.; Clarke N; The Christie and Salford Royal Hospitals, Manchester, UK.; Daugaard G; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; De Santis M; Department of Urology, Charité Universitätsmedizin, Berlin, Germany; Department of Urology, Medical University of Vienna, Austria.; Duran I; Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Cantabria, Spain.; Eeles R; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.; Efstathiou E; Houston Methodist Cancer Center, Houston, TX, USA.; Efstathiou J; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.; Ekeke ON; Department of Surgery, University of Port Harcourt Teaching Hospital, Alakahia, Port Harcourt, Nigeria.; Evans CP; University of California Davis School of Medicine, Sacramento, CA, USA.; Fanti S; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Feng FY; University of California, San Francisco, San Francisco, CA, USA.; Fonteyne V; Department of Radiation-Oncology, Ghent University Hospital, Ghent, Belgium.; Fossati N; Department of Urology, Ospedale Regionale di Lugano, Civico USI - Università della Svizzera Italiana, Lugano, Switzerland.; Frydenberg M; Department of Surgery, Prostate Cancer Research Program, Department of Anatomy & Developmental Biology, Faculty Nursing, Medicine & Health Sciences, Monash University, Melbourne, Australia.; George D; Departments of Medicine and Surgery, Duke Cancer Institute, Duke University, Durham, NC, USA.; Gleave M; Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.; Gravis G; Department of Medical Oncology, Institut Paoli Calmettes, Aix-Marseille Université, Marseille, France.; Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.; Heinrich D; Department of Oncology and Radiotherapy, Innlandet Hospital Trust, Gjøvik, Norway.; Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.; Higano C; University of British Columbia, Vancouver, British Columbia, Canada.; Hofman MS; Prostate Cancer Theranostics and Imaging Centre of Excellence, Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Horvath LG; Chris O'Brien Lifehouse, Camperdown, NSW, Australia; Garvan Institute of Medical Research, Darlinghurst, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia.; Hussain M; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.; Jereczek-Fossa BA; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Department of Radiotherapy, European Institute of Oncology (IEO) IRCCS, Milan, Italy.; Jones R; School of Cancer Sciences, University of Glasgow, United Kingdom.; Kanesvaran R; Division of Medical Oncology, National Cancer Centre, Singapore.; Kellokumpu-Lehtinen PL; Faculty of Medicine and Health Technology, Tampere University and Tampere Cancer Center, Tampere, Finland; Research, Development and Innovation Center, Tampere University Hospital, Tampere, Finland.; Khauli RB; Division of Urology and the Naef K. Basile Cancer Institute (NKBCI), American University of Beirut Medical Center, Beirut, Lebanon.; Klotz L; Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.; Kramer G; Department of Urology, Medical University of Vienna, Vienna, Austria.; Leibowitz R; Oncology Institute, Shamir Medical Center, Be'er Ya'akov, Israel; Faculty of Medicine, Tel-Aviv University, Israel.; Logothetis C; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; University of Athens Alexandra Hospital, Athens, Greece.; Mahal B; Department of Radiation Oncology, University of Miami Sylvester Cancer Center, Miami, FL, USA.; Maluf F; Beneficiência Portuguesa de São Paulo, São Paulo, SP, Brasil; Departamento de Oncologia, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.; Mateo J; Department of Medical Oncology and Prostate Cancer Translational Research Group. Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain.; Matheson D; Faculty of Education, Health and Wellbeing, Walsall Campus, Walsall, UK.; Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Merseburger A; Department of Urology, University Hospital Schleswig-Holstein, Luebeck, Germany.; Morgans AK; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Morris MJ; Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Mrabti H; National Institute of Oncology, Mohamed V University, Rabat, Morocco.; Mukherji D; Clemenceau Medical Center Dubai, United Arab Emirates, Faculty of Medicine, American University of Beirut, Lebanon.; Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; Murthy V; Tata Memorial Centre, Mumbai, India.; Nguyen PL; Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Oh WK; Chief, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA.; Ost P; Department of Human Structure and Repair, Ghent University, Ghent, Belgium; Department of Radiation Oncology, Iridium Netwerk, Antwerp, Belgium, Ghent University, Ghent, Belgium.; O'Sullivan JM; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Northern Ireland Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland.; Padhani AR; Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK.; Pezaro CJ; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Poon DMC; Comprehensive Oncology Centre, Hong Kong Sanatorium & Hospital, Hong Kong; The Chinese University of Hong Kong, Shatin, Hong Kong.; Pritchard CC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA.; Rabah DM; Cancer Research Chair and Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Department of Urology, KFSHRC Riyadh, Saudi Arabia.; Rathkopf D; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Reiter RE; University of California Los Angeles, Los Angeles, CA, USA.; Rubin MA; Bern Center for Precision Medicine and Department for Biomedical Research, Bern, Switzerland.; Ryan CJ; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Saad F; Centre Hospitalier de Université de Montréal, Montreal, Canada.; Sade JP; Instituto Alexander Fleming, Buenos Aires, Argentina.; Sartor O; Tulane Cancer Center, New Orleans, LA, USA.; Scher HI; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Sharifi N; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA; Department of Cancer Biology, GU Malignancies Research Center, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.; Skoneczna I; Rafal Masztak Grochowski Hospital, Maria Sklodowska Curie National Research Institute of Oncology, Warsaw, Poland.; Soule H; Prostate Cancer Foundation, Santa Monica, CA, USA.; Spratt DE; University Hospitals Seidman Cancer Center, Cleveland, OH, USA.; Srinivas S; Division of Medical Oncology, Stanford University Medical Center, Stanford, CA, USA.; Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, Division of Hematology and Oncology, Meyer Cancer Center, New York Presbyterian Hospital, New York, NY, USA.; Steuber T; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Suzuki H; Toho University Sakura Medical Center, Chiba, Japan.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Taplin ME; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Turkey.; Türkeri L; Department of Urology, M.A. Aydınlar Acıbadem University, Altunizade Hospital, Istanbul, Turkey.; Turco F; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Uemura H; Yokohama City University Medical Center, Yokohama, Japan.; Uemura H; Department of Urology, Kindai University Faculty of Medicine, Osaka, Japan.; Ürün Y; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey; Ankara University Cancer Research Institute, Ankara, Turkey.; Vale CL; University College London, MRC Clinical Trials Unit at UCL, London, UK.; van Oort I; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.; Vapiwala N; Department of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Walz J; Department of Urology, Institut Paoli-Calmettes Cancer Centre, Marseille, France.; Yamoah K; Department of Radiation Oncology & Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, Tampa, FL, USA.; Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Yu EY; Department of Medicine, Division of Oncology, University of Washington and Fred Hutchinson Cancer Center, G4-830, Seattle, WA, USA.; Zapatero A; Department of Radiation Oncology, Hospital Universitario de La Princesa, Health Research Institute, Madrid, Spain.; Zilli T; Radiation Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Omlin A; Onkozentrum Zurich, University of Zurich and Tumorzentrum Hirslanden Zurich, Switzerland.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Gillessen S; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Università della Svizzera Italiana, Lugano, Switzerland. Electronic address: silke.gillessen@eoc.ch.; Bossi A; Genitourinary Oncology, Prostate Brachytherapy Unit, Gustave Roussy, Paris, France.; Davis ID; Monash University and Eastern Health, Victoria, Australia.; de Bono J; The Institute of Cancer Research, London, UK; Royal Marsden Hospital, London, UK.; Fizazi K; Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.; James ND; The Institute of Cancer Research, London, UK.; Mottet N; University Jean Monnet, St Etienne, France.; Shore N; Carolina Urologic Research Center, Myrtle Beach, SC, USA; Urology/Surgical Oncology, GenesisCare, Myrtle Beach, SC, USA.; Small E; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Smith M; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Sweeney C; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Tombal B; Cliniques universitaires Saint Luc, Brussels, Belgium.; Antonarakis ES; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Aparicio AM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, NC, USA.; Attard G; University College London Cancer Institute, London, UK.; Beer TM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Beltran H; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Bjartell A; Department of Urology, Skåne University Hospital, Malmö, Sweden.; Blanchard P; Département de Radiothérapie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Briganti A; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.; Bristow RG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Christie NHS Trust and CRUK Manchester Institute and Cancer Centre, Manchester, UK.; Bulbul M; Division of Urology, Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon.; Caffo O; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy.; Castellano D; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Castro E; Institute of Biomedical Research in Málaga (IBIMA), Málaga, Spain.; Cheng HH; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA.; Chi KN; BC Cancer, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.; Chowdhury S; Guys and St Thomas's NHS Foundation Trust, London, UK.; Clarke CS; Research Department of Primary Care & Population Health, Royal Free Campus, University College London, London, UK.; Clarke N; The Christie and Salford Royal Hospitals, Manchester, UK.; Daugaard G; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; De Santis M; Department of Urology, Charité Universitätsmedizin, Berlin, Germany; Department of Urology, Medical University of Vienna, Vienna, Austria.; Duran I; Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Cantabria, Spain.; Eeles R; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.; Efstathiou E; Houston Methodist Cancer Center, Houston, TX, USA.; Efstathiou J; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.; Ngozi Ekeke O; Department of Surgery, University of Port Harcourt Teaching Hospital, Alakahia, Port Harcourt, Nigeria.; Evans CP; University of California Davis School of Medicine, Sacramento, CA, USA.; Fanti S; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Feng FY; University of California San Francisco, San Francisco, CA, USA.; Fonteyne V; Department of Radiation-Oncology, Ghent University Hospital, Ghent, Belgium.; Fossati N; Department of Urology, Ospedale Regionale di Lugano, Civico USI - Università della Svizzera Italiana, Lugano, Switzerland.; Frydenberg M; Department of Surgery, Prostate Cancer Research Program, Monash University, Melbourne, Australia; Department of Anatomy & Developmental Biology, Faculty of Nursing, Medicine & Health Sciences, Monash University, Melbourne, Australia.; George D; Department of Medicine, Duke Cancer Institute, Duke University, Durham, NC, USA; Department of Surgery, Duke Cancer Institute, Duke University, Durham, NC, USA.; Gleave M; Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.; Gravis G; Department of Medical Oncology, Institut Paoli Calmettes, Aix-Marseille Université, Marseille, France.; Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.; Heinrich D; Department of Oncology and Radiotherapy, Innlandet Hospital Trust, Gjøvik, Norway.; Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.; Higano C; University of British Columbia, Vancouver, British Columbia, Canada.; Hofman MS; Prostate Cancer Theranostics and Imaging Centre of Excellence, Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Horvath LG; Chris O'Brien Lifehouse, Camperdown, NSW, Australia; Garvan Institute of Medical Research, Darlinghurst, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia.; Hussain M; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.; Jereczek-Fossa BA; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Department of Radiotherapy, European Institute of Oncology (IEO) IRCCS, Milan, Italy.; Jones R; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Kanesvaran R; Division of Medical Oncology, National Cancer Centre, Singapore.; Kellokumpu-Lehtinen PL; Faculty of Medicine and Health Technology, Tampere University and Tampere Cancer Center, Tampere, Finland; Research, Development and Innovation Center, Tampere University Hospital, Tampere, Finland.; Khauli RB; Department of Urology and the Naef K. Basile Cancer Institute (NKBCI), American University of Beirut Medical Center, Beirut, Lebanon.; Klotz L; Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.; Kramer G; Department of Urology, Medical University of Vienna, Vienna, Austria.; Leibowitz R; Oncology Institute, Shamir Medical Center, Be'er Ya'akov, Israel; Faculty of Medicine, Tel-Aviv University, Israel.; Logothetis CJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; University of Athens Alexandra Hospital, Athens, Greece.; Mahal BA; Department of Radiation Oncology, University of Miami Sylvester Cancer Center, Miami, FL, USA.; Maluf F; Beneficiência Portuguesa de São Paulo, São Paulo, SP, Brasil; Departamento de Oncologia, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.; Mateo J; Department of Medical Oncology and Prostate Cancer Translational Research Group, Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain.; Matheson D; Faculty of Education, Health and Wellbeing, Walsall Campus, Walsall, UK.; Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Merseburger A; Department of Urology, University Hospital Schleswig-Holstein, Luebeck, Germany.; Morgans AK; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Morris MJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Mrabti H; National Institute of Oncology, Mohamed V University, Rabat, Morocco.; Mukherji D; Clemenceau Medical Center, Dubai, United Arab Emirates; Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; Murthy V; Tata Memorial Centre, Mumbai, India.; Nguyen PL; Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Oh WK; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA.; Ost P; Department of Radiation Oncology, Iridium Netwerk, Antwerp, Belgium; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.; O'Sullivan JM; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Northern Ireland Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland.; Padhani AR; Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK.; Pezaro C; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Poon DMC; Comprehensive Oncology Centre, Hong Kong Sanatorium & Hospital, Hong Kong; The Chinese University of Hong Kong, Shatin, Hong Kong.; Pritchard CC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Rabah DM; Cancer Research Chair and Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Department of Urology, KFSHRC, Riyadh, Saudi Arabia.; Rathkopf D; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Reiter RE; University of California Los Angeles, Los Angeles, CA, USA.; Rubin MA; Bern Center for Precision Medicine and Department for Biomedical Research, Bern, Switzerland.; Ryan CJ; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Saad F; Centre Hospitalier de Université de Montréal, Montreal, Quebec, Canada.; Pablo Sade J; Instituto Alexander Fleming, Buenos Aires, Argentina.; Sartor OA; Tulane Cancer Center, New Orleans, LA, USA.; Scher HI; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Sharifi N; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA; Department of Cancer Biology, GU Malignancies Research Center, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.; Skoneczna I; Rafal Masztak Grochowski Hospital, Maria Sklodowska Curie National Research Institute of Oncology, Warsaw, Poland.; Soule H; Prostate Cancer Foundation, Santa Monica, CA, USA.; Spratt DE; University Hospitals Seidman Cancer Center, Cleveland, OH, USA.; Srinivas S; Division of Medical Oncology, Stanford University Medical Center, Stanford, CA, USA.; Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, Division of Hematology and Oncology, Meyer Cancer Center, New York Presbyterian Hospital, New York, NY, USA.; Steuber T; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Suzuki H; Toho University Sakura Medical Center, Chiba, Japan.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Taplin ME; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Turkey.; Türkeri L; Department of Urology, M.A. Aydınlar Acıbadem University, Altunizade Hospital, Istanbul, Turkey.; Turco F; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Uemura H; Yokohama City University Medical Center, Yokohama, Japan.; Uemura H; Department of Urology, Kindai University Faculty of Medicine, Osaka, Japan.; Ürün Y; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey; Ankara University Cancer Research Institute, Ankara, Turkey.; Vale CL; University College London, MRC Clinical Trials Unit at UCL, London, UK.; van Oort I; Radboud University Medical Center, Nijmegen, The Netherlands.; Vapiwala N; Department of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Walz J; Department of Urology, Institut Paoli-Calmettes Cancer Centre, Marseille, France.; Yamoah K; Department of Radiation Oncology & Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, Tampa, FL, USA.; Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Yu EY; Department of Medicine, Division of Oncology, University of Washington and Fred Hutchinson Cancer Center, Seattle, WA, USA.; Zapatero A; Department of Radiation Oncology, Hospital Universitario de La Princesa, Health Research Institute, Madrid, Spain.; Zilli T; Radiation Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Omlin A; Onkozentrum Zurich, University of Zurich and Tumorzentrum Hirslanden Zurich, Switzerland.
Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Academic Journal
James ND; Institute of Cancer Research, London, UK.; Clarke NW; The Departments of Surgery & Urology, The Christie & Salford Royal Hospitals, Manchester, UK.; Cook A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.; Ali A; The Christie NHS Foundation Trust, Manchester, UK.; Hoyle AP; Salford Royal HS Foundation Trust, Manchester, UK.; Attard G; UCL Cancer Institute, University College London, London, UK.; Brawley CD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.; Chowdhury S; Guy's, King's, & St. Thomas' Hospitals, and Sarah Cannon Research Institute, London, UK.; Cross WR; St James University Hospital, Leeds, UK.; Dearnaley DP; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.; de Bono JS; Institute of Cancer Research, London, UK.; Diaz-Montana C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.; Gilbert D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.; Gillessen S; Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland.; Gilson C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.; Royal Marsden Hospital, London, UK.; Jones RJ; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK.; Langley RE; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.; Malik ZI; Radiotherapy Unit, The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, Liverpool, L7 8YA, UK.; Matheson DJ; School of Allied Health and Midwifery, Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, WS1 3BD, UK.; Millman R; (PPI) c/o MRC CTU at UCL, London, UK.; Parker CC; Uro-Oncology Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK.; Pugh C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.; Rush H; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.; Guys and St Thomas' NHS Foundation Trust, London, UK.; Russell JM; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Beatson West of Scotland Cancer Centre, Glasgow, UK.; Berthold DR; Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.; Buckner ML; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.; Mason MD; Cardiff University, School of Medicine, Cardiff, UK.; Ritchie AWS; Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK.; Birtle AJ; Rosemere Cancer Centre, Lancashire Teaching Hospitals & University of Manchester, University of Central Lancashire, Lancashire, UK.; Brock SJ; University Hospital Dorset, Bournemouth, UK.; Das P; Department of Oncology, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.; Ford D; City Hospital, Cancer Centre at Queen Elizabeth Hospital, Birmingham, UK.; Gale J; Portsmouth Hospitals University Trust, Portsmouth, UK.; Grant W; Gloucestershire Oncology Centre, Cheltenham General Hospital, Cheltenham, UK.; Gray EK; Musgrove Park Hospital, Taunton, UK.; Hoskin P; Mount Vernon Cancer Centre, Northwood, UK.; Khan MM; Department of Oncology Castle Hill Hospital, Hull, UK.; Scarborough General Hospital, Scarborough, UK.; Manetta C; Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.; McPhail NJ; Department of Clinical Oncology, Raigmore Hospital, Inverness, UK.; O'Sullivan JM; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.; Parikh O; Rosemere Cancer Centre, Lancashire Teaching Hospitals NHS Trust, Preston, UK.; Perna C; Royal Surrey NHS Foundation Trust, Guildford, UK.; Pezaro CJ; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Protheroe AS; Oxford University Hospitals NHS Foundation Trust, Oxfordshire, UK.; Robinson AJ; Sussex Cancer Centre, Brighton, UK.; Rudman SM; Guys and St Thomas' NHS Foundation Trust, London, UK.; Sheehan DJ; Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.; Srihari NN; Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK.; Syndikus I; Radiotherapy Unit, The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, Liverpool, L7 8YA, UK.; Tanguay JS; Velindre Cancer Centre, Cardiff, UK.; Thomas CW; Kent Oncology Centre, Maidstone, Kent, UK.; Vengalil S; University Hospital North Midlands NHS Trust, Staffordshire, UK.; Wagstaff J; Swansea University and the South West UK Cancer Centre, Swansea, UK.; Wylie JP; The Christie NHS Foundation Trust, Manchester, UK.; Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Academic Journal
Lawrence MG; Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Porter LH; Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.; Choo N; Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.; Pook D; Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.; Medical Oncology, Monash Health, Clayton, Victoria, Australia.; Grummet JP; Epworth Healthcare, Melbourne, Victoria, Australia.; Department of Surgery, Central Clinical School, Monash University, Clayton, Victoria, Australia.; Australian Urology Associates, Melbourne, VIC, Australia.; Pezaro CJ; Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.; Eastern Health and Monash University Eastern Health Clinical School, Victoria, Australia.; University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Sandhu S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Cancer Tissue Collection After Death (CASCADE) Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Ramm S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Luu J; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Bakshi A; Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.; Computational Cancer Biology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Goode DL; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Computational Cancer Biology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sanij E; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Clinical Pathology, University of Melbourne, Parkville, Victoria, Australia.; St Vincent's Institute, Fitzroy, VIC, Australia.; Pearson RB; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia.; Hannan RD; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia.; ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, Australian National University, Australian Capital Territory, Australia.; School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia.; Simpson KJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Taylor RA; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. luc.furic@petermac.org renea.taylor@monash.edu gail.risbridger@monash.edu.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Physiology, Monash University, Clayton, Victoria, Australia.; Risbridger GP; Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia. luc.furic@petermac.org renea.taylor@monash.edu gail.risbridger@monash.edu.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Furic L; Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia. luc.furic@petermac.org renea.taylor@monash.edu gail.risbridger@monash.edu.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Academic Journal
Risbridger GP; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia. gail.risbridger@monash.edu.; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. gail.risbridger@monash.edu.; Clark AK; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Porter LH; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Toivanen R; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Bakshi A; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Computational Cancer Biology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Lister NL; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Pook D; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.; Department of Medical Oncology, Monash Health, Clayton, VIC, Australia.; Pezaro CJ; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Eastern Health and Monash University Eastern Health Clinical School, Box Hill, VIC, Australia.; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, England.; Sandhu S; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Cancer Tissue Collection After Death (CASCADE) Program, Melbourne, VIC, Australia.; Keerthikumar S; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Computational Cancer Biology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Quezada Urban R; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Computational Cancer Biology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Papargiris M; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Australian Prostate Cancer Bioresource, VIC Node, Monash University, Clayton, VIC, Australia.; Kraska J; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Australian Prostate Cancer Bioresource, VIC Node, Monash University, Clayton, VIC, Australia.; Madsen HB; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Australian Prostate Cancer Bioresource, VIC Node, Monash University, Clayton, VIC, Australia.; Wang H; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Richards MG; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Niranjan B; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; O'Dea S; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Teng L; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Wheelahan W; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Li Z; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Physiology, Monash University, Clayton, VIC, Australia.; Choo N; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Ouyang JF; Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore, Singapore.; Thorne H; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Devereux L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Hicks RJ; Center for Molecular Imaging, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.; Sengupta S; Eastern Health and Monash University Eastern Health Clinical School, Box Hill, VIC, Australia.; Department of Urology, Austin Hospital, The University of Melbourne, Heidelberg, VIC, Australia.; Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, VIC, Australia.; Epworth Healthcare, Melbourne, VIC, Australia.; Epworth Freemasons, Epworth Health, East Melbourne, VIC, Australia.; Harewood L; Epworth Healthcare, Melbourne, VIC, Australia.; Department of Surgery, The University of Melbourne, Parkville, VIC, Australia.; Iddawala M; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.; Azad AA; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Goad J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Epworth Healthcare, Melbourne, VIC, Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, VIC, Australia.; Grummet J; Epworth Healthcare, Melbourne, VIC, Australia.; Department of Surgery, Central Clinical School, Monash University, Clayton, VIC, Australia.; Australian Urology Associates, Melbourne, VIC, Australia.; Kourambas J; Department of Medicine, Monash Health, Casey Hospital, Berwick, VIC, Australia.; Kwan EM; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.; Department of Medical Oncology, Monash Health, Clayton, VIC, Australia.; Moon D; Epworth Healthcare, Melbourne, VIC, Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, VIC, Australia.; Australian Urology Associates, Melbourne, VIC, Australia.; Central Clinical School, Monash University, Clayton, VIC, Australia.; The Epworth Prostate Centre, Epworth Hospital, Richmond, VIC, Australia.; Murphy DG; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Epworth Healthcare, Melbourne, VIC, Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, VIC, Australia.; Pedersen J; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; TissuPath, Mount Waverley, VIC, Australia.; Clouston D; TissuPath, Mount Waverley, VIC, Australia.; Norden S; TissuPath, Mount Waverley, VIC, Australia.; Ryan A; TissuPath, Mount Waverley, VIC, Australia.; Furic L; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Goode DL; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Computational Cancer Biology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Frydenberg M; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Epworth Healthcare, Melbourne, VIC, Australia.; Australian Urology Associates, Melbourne, VIC, Australia.; Department of Surgery, Monash University, Clayton, VIC, Australia.; Department of Urology, Cabrini Institute, Cabrini Health, Melbourne, VIC, Australia.; Lawrence MG; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Taylor RA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. renea.taylor@monash.edu.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. renea.taylor@monash.edu.; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Physiology, Monash University, Clayton, VIC, Australia. renea.taylor@monash.edu.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Annala M; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Fu S; Department of Medical Oncology, BC Cancer, Vancouver, Canada; Oncology, School of Medical Sciences, University of Auckland, Auckland, New Zealand.; Bacon JVW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Sipola J; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Iqbal N; Medical Oncology, Saskatoon Cancer Centre, University of Saskatchewan, Saskatoon, Canada.; Ferrario C; Jewish General Hospital, McGill University, Montréal, Quebec, Canada.; Ong M; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, Canada.; Wadhwa D; BC Cancer - Kelowna Centre, Kelowna, Canada.; Hotte SJ; Oncology, Juravinski Cancer Centre, Hamilton, Canada.; Lo G; Department of Medical Oncology, R. S. McLaughlin Durham Regional Cancer Centre, Lakeridge Health, Oshawa, Canada.; Tran B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Wood LA; QEII Health Sciences Centre, Halifax, Canada.; Gingerich JR; Department of Medical Oncology and Hematology, Cancer Care Manitoba, Winnipeg, Canada.; North SA; Department of Oncology, University of Alberta, Edmonton, Canada.; Pezaro CJ; Eastern Health Clinical School, Monash University, Australia; Department of Oncology, Eastern Health, Australia.; Ruether JD; Tom Baker Cancer Centre, Calgary, Canada.; Sridhar SS; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; Kallio HML; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Khalaf DJ; Department of Medical Oncology, BC Cancer, Vancouver, Canada.; Wong A; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Beja K; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Schönlau E; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Taavitsainen S; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Nykter M; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Vandekerkhove G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Azad AA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada. Electronic address: awwyatt@mail.ubc.ca.; Chi KN; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Department of Medical Oncology, BC Cancer, Vancouver, Canada. Electronic address: kchi@bccancer.bc.ca.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Rescigno P; The Institute of Cancer Research, Sutton, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK; University of Naples Federico II, Naples, Italy.; Dolling D; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.; Conteduca V; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy.; Rediti M; The Institute of Cancer Research, Sutton, UK; Jules Bordet Institut, Brussels, Belgium.; Bianchini D; The Royal Marsden NHS Foundation Trust, Sutton, UK.; Lolli C; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy.; Ong M; The Ottawa Hospital Cancer Centre, Ottawa, Canada.; Li H; The Ottawa Hospital Cancer Centre, Ottawa, Canada.; Omlin AG; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, University of Bern, Bern, Switzerland.; Schmid S; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, University of Bern, Bern, Switzerland.; Caffo O; Santa Chiara Hospital, Trento, Italy.; Zivi A; Ospedale dell'Angelo Mestre, AULSS3 Serenissima, UOC Oncologia, Venice, Italy.; Pezaro CJ; Monash University and Eastern Health, Box Hill, Australia.; Morley C; Monash University and Eastern Health, Box Hill, Australia.; Olmos D; Spanish National Cancer Research Center, Madrid, Spain.; Romero-Laorden N; Spanish National Cancer Research Center, Madrid, Spain.; Castro E; Spanish National Cancer Research Center, Madrid, Spain.; Saez MI; Hospital Virgen de la Victoria, Malaga, Spain.; Mehra N; Department of Medical Oncology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.; Smeenk S; Department of Medical Oncology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.; Sideris S; Jules Bordet Institut, Brussels, Belgium.; Gil T; Jules Bordet Institut, Brussels, Belgium.; Banks P; Division of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sandhu SK; Division of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York-Presbyterian, New York, NY, USA.; De Giorgi U; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy.; De Bono JS; The Institute of Cancer Research, Sutton, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK. Electronic address: johann.de-bono@icr.ac.uk.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Pezaro CJ
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어